RNA Outsourcing Solutions

  1. Simplify Your mRNA Workflow From The Start 4/24/2026

    Cell‑free DNA simplifies mRNA production by removing bacterial risk, stabilizing polyA tails, and eliminating extra steps — delivering higher yields and cleaner workflows.

  2. GMP mRNA And LNP-mRNA Manufacturing 5/13/2024

    Easily scale your GMP mRNA projects

  3. Expert Partnership Contract Testing Services 2/13/2024

    Learn about our best-in-class, risk-mitigating solutions with technical and regulatory expertise to help you bring life-changing drugs to market .

  4. Help Your Program Thrive With inSeption Group 6/13/2024

    Experience the difference that dedicated, top-tier professionals can make in achieving excellence and innovative solutions in clinical outsourcing.

  5. Advancing Innovative Plasmid DNA Manufacturing Solutions For CGT 3/13/2025

    Having produced over 185,000 DNA lots, including 5,000+ cGMP batches, we are a trusted partner in plasmid DNA production from discovery to commercialization.

  6. Drug Product Manufacturing: Scaling Product From Bench To Market 5/7/2025

    Curia offers comprehensive development and manufacturing services to meet needs through the entire lifecycle of your sterile drug product. Leverage our in-depth expertise and capabilities at any scale, from early clinical through large-scale commercial.

  7. Cell Therapy Product Characterization Services

    Our cell therapy product characterization services combine rapid PCR, ELISA and custom methods tailored to these product types from a single contract partner with fully compliant cGMP facilities and options for research grade testing available.

  8. CMC: Accelerate Your Drug Development With A Global Partner 12/2/2025

    With the right Chemistry, Manufacturing & Controls (CMC) consulting services, your organization can excel in early-stage strategizing, accelerate timelines, optimize processes, and reduce costs.

  9. Toxicology Support: Regulatory Strategy And Submission Support 12/2/2025

    Eliminate delays and ensure seamless regulatory alignment with an experienced toxicology services team.

  10. The Early Advantage For mRNA 10/9/2026

    Developing mRNA treatments requires expertise in process development and LNP encapsulation for small biotech companies.